Sex differences in nicotine effects and self-administration: Review of human and animal evidence

Nicotine and Tobacco Research

Volumn 1, Issue 4, 1999, Pages 301-315

  Perkins, Kenneth A ^a,c   Donny, Eric ^b   Caggiula, Anthony R ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLION STIMULATING AGENT; NICOTINE;

ANIMAL; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; REVIEW; SEX DIFFERENCE; TOBACCO DEPENDENCE;

ANIMALS; FEMALE; GANGLIONIC STIMULANTS; HUMANS; MALE; NICOTINE; SELF ADMINISTRATION; SEX FACTORS; TOBACCO USE DISORDER;

EID: 0033286715     PISSN: 14622203     EISSN: None     Source Type: Journal    
DOI: 10.1080/14622299050011431     Document Type: Review

References (155)

1. Alexander BK, Coambs RB, Hadaway PF. 1978. The effect of housing and gender on morphine self-administration in rats. Psychopharmacology 58:175-179.
2. Allen SS, Hatsukami DK, Christianson D, Nelson D. 1999. Withdrawal and pre-menstrual symptomatology during the menstrual cycle in short-term smoking abstinence: effects of menstrual cycle on smoking abstinence. Nicotine & Tobacco Research 1:129-142.
3. Almeida OFX, Shoaib M, Deicke J, Fischer D, Darwish MH, Patchev VK. 1998. Gender differences in ethanol preference and ingestion in rats: the role of the gonadal steroid environment. Journal of Clinical Investigation 101:2677-2685.
4. Andersson K, Eneroth P, Fuxe K, Mascagni F, Agnati L. 1985. Effects of chronic exposure to cigarette smoke on amine levels and turnover in various hypothalamic catecholamine nerve terminal systems and on the secretion of pituitary hormones in the male rat. Neuroendocrinology 41:462-466
5. Andersson K, Eneroth P, Fuxe K. 1988. Effects of acute intermittent exposure to cigarette smoke on hypothalamic and preoptic cate-cholamine nerve terminals systems and on neuroendocrine function in the diestrous rat. Naunyn-Schmiedeberg's Archives of Pharmacology 337:131-139.
6. Baldinger B, Hasenfratz M, Battig K. 1995. Switching to ultralow nicotine cigarettes: effects of different tar yields and blocking of olfactory cues. Pharmacology, Biochemistry, and Behavior 50:233-239.
7. Becker JB. 1990. Direct effect of 17-beta-estradiol on striatum: Sex differences in dopamine release. Synapse 5:157-164
8. Benowitz NL, Hatsukami DK. 1998. Gender differences in the pharmacology of nicotine addiction. Addiction Biology 3:383-404.
9. Bjornson W, Rand C, Connett JE, Lindgren P, Nides M, Pope F, Buist AS, Hoppe-Ryan C, O'Hara P. 1995. Gender differences in smoking cessation after 3 years in the Lung Health Study. American Journal of Public Health 85:223-230.
10. Blake SM, Klepp K-I, Pechacek TF, Folsom AR, Luepker RV, Jacobs DR, Mittlemark MB. 1989. Differences in smoking cessation strategies between men and women. Addictive Behaviors 14:409-418.
11. Bryson R, Biner PM, McNair E, Bergondy M, Abrams OR. 1981. Effects of nicotine on two types of motor activity in rats. Psychopharmacology 73:168-170
12. Centers for Disease Control (CDC). 1990. Cigarette smoking cessation - United States, 1989. Morbidity and Mortality Weekly Report, 39:676-680.
13. Centers for Disease Control (CDC). 1998. State-specific prevalence among adults of current cigarette smoking - United States, 1997. Morbidity and Mortality Weekly Report, 47:922-926.
14. Chait LD. 1994. Factors influencing the reinforcing and subjective effects of ephedrine in humans. Psychopharmacology 113:381-387.
15. Collins AC, Romm E, Wehner JM. 1988. Nicotine tolerance: an analysis of the time course of its development and loss in the rat. Psychopharmacology 96:7-14.
16. Cox B, Goldstein A, Nelson W. 1984. Nicotine self-administration in rats. British Journal of Pharmacology 83:49-55.
17. Craft RM, Milholland RB. 1998. Sex differences in cocaine- and nicotine-induced antinociception in the rat. Brain Research 809:137-140.
18. Craft RM, Stratmann JA. 1996. Sex differences in the discriminative stimulus properties of cocaine in the rat. Drug and Alcohol Dependence 42:27-37.
19. Cronan T, Bryson R, McNair E. 1984. Effect of sex and castration on nicotine-induced activity reponses. Pharmacology, Biochemistry, and Behavior 21:675-677
20. Cronan T, Conrad J, Bryson R. 1985. Effects of chronically administered nicotine and saline on motor activity in rats. Pharmacology, Biochemistry and Behavior 22:897-899.
21. Davidson TL, Flynn FW, Jarrard LE. 1992. Potency of food deprivation intensity cues as discriminative stimuli. Journal of Experimental Psychology: Animal Behavior Processes 18:174-181.
22. DeBon M, Klesges RC, Klesges LM. 1995. Symptomatology across the menstrual cycle in smoking and nonsmoking women. Addictive Behaviors 20:335-343.
23. Della Casa V, Hofer I, Weiner I, Feldon J. 1998. The effects of smoking on acoustic prepulse inhibition in healthy men and women. Psychopharmacology 137:362-368.
24. Dluzen DE, Anderson LI. 1997. Estrogen differentially modulates nicotine-evoked dopamine release from the striatum of male and female rats. Neuroscience Letters 230:140-142.
25. Donny EC. 1999. Evaluating potential sex differences in the reinforcing effects of nicotine. Unpublished PhD dissertation, University of Pittsburgh.
26. Donny EC, Caggiula AR, Knopf S, Brown C. 1995. Nicotine self-administration in rats. Psychopharmacology 122:390-394.
27. Donny EC, Caggiula A, Mielke M, Jacobs KS, Rose C, Sved AF. 1998a. Acquistion of nicotine self-administration in rats: the effects of dose, feeding schedule, and drug contingency. Psychopharmacology 136:83-90.
28. Donny EC, Caggiula AR, Shupanko CD, Mielke MM, Booth S, Hoffman AS, Imerito CA, Rose C, McCallum SE. 1998b. Nicotine self-administration in male and female rats on fixed and progressive ratio schedules of reinforcement (Abst). Society for Neuroscience Abstracts, #294.11.
29. Donny EC, Caggiula AR, Mielke MM, Booth S, Gharib MA, Hoffman A, Maldovan V, Shupenko C, McCallum SE. In press. Nicotine self-administration in rats on a progressive ratio schedule of reinforcement. Psychopharmacology.
30. Doty P, deWit H. 1995. Effect of setting on the reinforcing and subjective effects of ethanol in social drinkers. Psychopharmacology 118:19-27.
31. Duka T, Stephens DN, Russell C, Tasker R. 1998. Discriminative stimulus properties of low doses of ethanol in humans. Psychopharmacology 136:379-389.
32. Eisinger RA. 1971. Psychosocial predictors of smoking recidivism. Journal of Health & Social Behavior 12:355-362.
33. Faraday MM, Scheufle PM, Rahman MA, Grunberg NE. 1999. Effects of chronic nicotine administration on locomotion depend on rat sex and housing condition. Nicotine & Tobacco Research 1:143-151.
34. Fiore MC. 1992. Trends in cigarette smoking in the United States. Medical Clinics of North America 76:289-303.
35. Fiore MC, Smith SS, Jorenby DE, Baker TB. 1994. The effectiveness of the nicotine patch for smoking cessation: a meta-analysis. Journal of the American Medical Association 271:1940-1947.
36. Florentine R, Anglin MD, Gil-Rivas V, Taylor E. 1997. Drug treatment: explaining the gender paradox. Substance Use and Misuse 32:653-678.
37. Forgie ML, Stewart J. 1994. Sex differences in the locomotor-activating effects of amphetamine: role of circulating testosterone in adulthood. Physiology and Behavior 55:639-644.
38. Fortmann SP, Killen JD. 1994. Who shall quit? Comparison of volunteer and population-based recruitment in two minimal-contact smoking cessation studies. American Journal of Epidemiology 140:39-51.
39. Gallant SJ, Hamilton JA, Popiel DA, Morokoff PJ, Chakraborty PK. 1991. Daily moods and symptoms: effects of awareness of study focus, gender, menstrual cycle phase, and day of the week. Health Psychology 10:180-189.
40. Gear RW, Miaskowski C, Gordon NC, Paul SN, Heller PH, Levine JD. 1996. Kappa-opioids produce significantly greater analgesia in women than in men. Nature Medicine 2:1248-1250.
41. Giovino GA, Henningfield JE, Tomar SL, Escobedo LG, Slade J. 1995. Epidemiology of tobacco use and dependence. Epidemiologic Reviews 17:48-65.
42. Glassman AH, Stetner F, Walsh BT, Raizman P, Fleiss JL, Cooper TB, Covey LS. 1988. Heavy smokers, smoking cessation, and clonidine. Journal of the American Medical Association 259:2863-2866.
43. Glick SD, Visker KE, Maisonneuve IM. 1996. An oral self-administration model nicotine preference in rats: effects of mecamylamine. Psychopharmacology 128:426-431.
44. Glick SD, Maissonneuve IM, Visker KE, Fritz KA, Bandarage UK, Kuehne ME. 1998. 18-methoxycoronardine attenuates nicotine-induced dopamine release and nicotine preferences in rats. Psychopharmacology 139:274-280.
45. Grant KA, Azarov A, Shively CA, Purdy RH. 1997. Discriminative stimulus effects of ethanol and 3 alpha-hydroxy-5 alpha pregnan-20-One in relation to menstrual cycle phase in cynomolgus monkeys. Psychopharmacology 130:59-68.
46. Grobe JE. 1999. The importance of controllability over drug intake in moderating the effects of tobacco smoking. Unpublished PhD dissertation, University of Pittsburgh.
47. Grobe JE, Perkins KA. 1997. Gender differences in the effects of nicotine on thermal pain sensitivity. Society for Research on Nicotine and Tobacco (SRNT) annual meeting abstracts, p. 38.
48. Grunberg NE, Faraday MM. in press. The value of animal models to examine the Gateway Hypothesis. In Kandel D et al., eds. Stages and Pathways of Involvement in Drug Use. New York: Cambridge University Press.
49. Grunberg NE, Winders SE, Wewers ME. 1991. Gender differences in tobacco use. Health Psychology 10:143-153.
50. Hamilton JA, Yonkers KA. 1996. Sex differences in pharmacokinetics of psychotropic medications, part I: physiological basis for effects. In MF Jensvold et al., eds. Psychopharmacology and Women: Sex, Gender, and Hormones. Washington DC: American Psychiatric Press, pp. 11-42.
51. Hadaway PF, Alexander BK, Coambs RB, Beyerstein D. 1979. The effect of housing and gender on preference for morphine-sucrose solutions in rats. Psychopharmacology 66:87-91.
52. Hatchell P, Collins A. 1977. Influence of genotype and sex on behavioral tolerance to nicotine in mice. Pharmacology, Biochemistry, and Behavior 6:25-30.
53. Hatchell P, Collins A. 1980. The influence of genotype and sex on behavioral sensitvity to nicotine in mice. Psychopharmacology 71:45-49.
54. Hatsukami D, Skoog K, Allen S, Bliss R. 1995. Gender and the effects of different doses of nicotine gum on tobacco withdrawal symptoms. Experimental and Clinical Psychopharmacology 3:163-173.
55. Hughes JR. 1996. Pharmacotherapy of nicotine dependence. In: Schuster CR, Kuhar MJ, eds. Pharmacological Aspects of Drug Dependence: Toward an Integrative Neurobehavioral Approach. New York: Springer-Verlag, pp. 599-626.
56. Hughes JR, Hatsukami D. 1986. Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry 43:289-294.
57. Jamner LD, Girdler SS, Shapiro D, Jarvik ME. 1998. Pain inhibition, nicotine, and gender. Experimental and Clinical Psychopharmacology 6:96-106.
58. Janowsky DS, Halbreich U, Rausch J. 1996. Association among ovarian hormones, other hormones, emotional disorders, and neurotransmitters. In: Jensvold MF, Halbreich U, Hamilton JA, eds. Psychopharmacology and Women: Sex, Gender, and Hormones. American Psychiatric Press, Inc., Washington D.C., pp. 85-106.
59. Jansson A, Andresson K, Fuxe K, Bjelke B, Eneroth P. 1989. Effects of combined pre- and postnatal treatment with nicotine on hypothalamic catecholamine nerve terminal systems and neuroendocrine function in the four week old and adult male and female diestrous rat Journal of Neuroendocrinology 1:455-464
60. Jensvold MF, Hamilton JA, Halbreich U. 1996. Future research directions: methodological considerations for advancing gender-sensitive pharmacology. In MF Jensvold et al., eds. Psychopharmacology and Women: Sex, Gender, and Hormones. Washington DC: American Psychiatric Press, pp. 415-430.
61. Kabat GC, Wynder EL. 1987. Determinants of quitting smoking. American Journal of Public Health 77:1301-1305.
62. Ke L, Lukas RJ. 1996. Effects of steroid exposure on ligand binding and functional activities of diverse nicotinic acetylcholine receptor subtypes. Journal of Neurochemistry 67:1100-1112
63. Killen JD, Fortmann SP, Newman B, Varady A. 1990. Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. Journal of Consulting and Clinical Psychology 58:85-92.
64. Killen JD, Robinson TN, Haydel KF, Hayward C, Wilson DM, Hammer LD, Litt IF, Taylor CB. 1997. Prospective study of risk factors for the initiation of cigarette smoking. Journal of Consulting and Clinical Psychology 65:1011-1016.
65. Koylu E, Demirgoren S, London E. 1997. Sex differences in up-regulation of nicotinic acetycholine receptors in the rat brain. Life Sciences 61:185-190.
66. Kure EH, Ryberg D, Hewer A, Phillips DH, Skaug V, Baera R, Haugen A. 1996. p53 mutations in lung tumours: relationship to gender and lung DNA adduct levels. Carcinogenesis 17:2201-2205.
67. Kyerematen GA, Owens GF, Chattopadhyay B. 1988. Sexual dimorphism of nicotine metabolism and distribution in the rat. Journal of Pharmacology and Experimental Therapeutics 246:823-828
68. Lancaster FE, Spiegel KS. 1992. Sex differences in pattern of drinking. Alcohol 9:415-420.
69. Laviola G, Dell'Omo G, Alleva E, Bignami G. 1992. Ontogeny of cocaine hyperactivity and conditioned place preference in mice. Psychopharmacology 107:221-228.
70. Lazev AB, Herzog TA, Brandon TH. 1999. Classical conditioning of environmental cues to cigarette smoking. Experimental and Clinical Psychopharmacology 7:56-63.
71. Levin ED, Conners CK, Sparrow E, Hinton SC, Erhardt D, Meck WH, Rose JE, March J. 1996. Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology 123:55-63.
72. Lukas SE, Sholar MB, Fortin M, Wines J, Mendelson JH. 1996. Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers. Psychopharmacology 125:346-354.
73. Maehler R, Kameda G, Dadmarz M, Vogel WH. 1998. Effects of various factors and drugs on the voluntary intake of nicotine by rats. Naunyn-Schmiedebergs Archives of Pharmacology 358:R785.
74. Majewska MD. 1996. Sex differences in brain morphology and pharmacodynamics. In: Jensvold MF, Halbreich U, Hamilton JA, eds. Psychopharmacology and Women: Sex, Gender, and Hormones. American Psychiatric Press, Inc., Washington D.C., pp. 73-84.
75. Markou A, Weiss F, Gold L, Caine S, Schulteis G, Koob G. 1993. Animal models of drug craving. Psychopharmacology 112:163-182.
76. Marks JL, Hair CS, Klock SC, Ginsburg BE, Pomerleau CS. 1994. Effects of menstrual phase on intake of nicotine, caffeine, and alcohol and non-prescribed drugs in women with late luteal phase dysphoric disorder. Journal of Substance Abuse 6:235-243.
77. Marks JL, Pomerleau CS, Pomerleau OF. 1999. Effects of menstrual phase on reactivity to nicotine. Addictive Behaviors 24:127-134.
78. McDermott JL. 1993. Effects of estrogen upon dopamine release from the corpus striatum of young and aged female rats. Brain Research 606:118-125.
79. McDermott JL, Liu B, Dluzen DE. 1994. Sex differences and effects of estrogen on dopamine and DOPAC release from the striatum of male and female CD-1 mice. Experimental Neurology 125:306-311
80. McGivern RF, Huston JP, Byrd D, King T, Siegle GJ, Reilly J. 1997. Sex differences in visual recognition memory: support for a sex-related difference in attention in adults and children. Brain and Cognition 34:323-336.
81. McGregor A, Roberts DCS. 1993. Dopaminergic antagonism within the nucleus accumbens or amygdala produce differential effects on intravenous cocaine self-administration under fixed and progressive ratio schedules of reinforcement. Behavior and Brain Research 624:245-252.
82. McGregor A, Roberts DCS. 1995. Effect of medial prefrontal cortex injections of SCH-23390 on intravenous cocaine self-administration under both a fixed and progressive-ratio schedule of reinforcement. Behavior and Brain Research 67:75-80.
83. Meehan SM, Schechter MD. 1998. LSD produces conditioned place preference in male but not female fawn hooded rats. Pharmacology, Biochemistry, and Behavior 59:105-108.
84. Mendrek A, Blaha CD, Phillips AG. 1998. Pre-exposure of rats to amphetamine sensitizes self-administration of this drug under a progressive ratio schedule. Psychopharmacology 135:416-422.
85. Mennella JA, Beauchamp GK. 1998. Smoking and the flavor of breast milk. New England Journal of Medicine 339:1559-1560.
86. Mochizuki T, Villemagne VL, Scheffel U, Dannals RF, Finley P, Zhan YG, Wagner HNJ, Musachio JL. 1998. Nicotine induced up-regulation of nicotinic receptors in CD-1 mice demonstrated with an in vivo radiotracer: gender differences. Synapse 30:116-118
87. Nides MA, Rakos RF, Gonzales D, Murray RP, Tashkin DP, Bjornson-Benson WM, Lindgren P, Connett JE. 1995. Predictors of initial smoking cessation and relapse through the first two years of the Lung Health Study. Journal of Consulting and Clinical Psychology 63:60-69.
88. Nwoso C, Crooks P. 1988. Species variation and stereoselectivity in the metabolism of nicotine enantiomers. Xenobiotica 18:1361-1372
89. Ockene JK. 1993. Smoking among women across the lifespan: prevalence, interventions, and implications for cessation research. Annals of Behavioral Medicine 15:135-148.
90. O'Hara P, Portser SA, Anderson BP. 1989. The influence of menstrual cycle changes on the tobacco withdrawal syndrome in women. Addictive Behaviors 14:595-600.
91. Opitz K, Weischler ML. 1988. Volitional oral intake of nicotine in tupaias: drug-induced alterations. Drug and Alcohol Dependence 21:99-104.
92. Overmier JB. 1992. On the nature of animal models of human behavioral dysfunction. In JB Overmier, PD Burke, eds. Animal Models of Human Pathology. Washington DC: American Psychological Association, pp. vii-xiv.
93. Parrott AC, Craig D. 1995. Psychological functions served by nicotine chewing gum. Addictive Behaviors 20:271-278.
94. Perkins KA. 1996. Sex differences in nicotine versus non-nicotine reinforcement as determinants of tobacco smoking. Experimental and Clinical Psychopharmacology 4:166-177.
95. Perkins KA. 1999. Nicotine discrimination in men and women. Pharmacology, Biochemistry, and Behavior 64: 295-299.
96. Perkins KA, Stitzer M. 1998. Behavioral pharmacology of nicotine. In Tarter R et al., eds. Handbook of Substance Abuse: Neurobehavioral Pharmacology. New York: Ayllon & Bacon; pp. 299-317.
97. Perkins KA, Grobe JE, Stiller RL, Fonte C, Goettler JE. 1992. Nasal spray nicotine replacement suppresses cigarette smoking desire and behavior. Clinical Pharmacology and Therapeutics 52:627-634.
98. Perkins KA, Grobe JE, Fonte C, Goettler JL, Caggiula AR, Reynolds WA, Stiller RL, Scierka A, Jacob RG. 1994a. Chronic and acute tolerance to subjective, behavioral, and cardiovascular effects of nicotine in humans. Journal of Pharmacology and Experimental Therapeutics 270:628-638.
99. Perkins KA, Epstein LH, Grobe JE, Fonte C. 1994b. Tobacco abstinence, smoking cues, and the reinforcing value of smoking. Pharmacology Biochemistry and Behavior 47:107-112.
100. Perkins KA, Sexton JE, Reynolds WA, Grobe JE, Fonte C, Stiller RL. 1994c. Comparison of acute subjective and heart rate effects of nicotine intake via tobacco smoking versus nasal spray. Pharmacology Biochemistry and Behavior 47:295-299.
101. Perkins KA, Sexton JE, Epstein LH, DiMarco A, Fonte C, Stiller RL, Scierka A, Jacob RG. 1994d. Acute thermogenic effects of nicotine combined with caffeine during light physical activity in male and female smokers. American Journal of Clinical Nutrition 60:312-319.
102. Perkins KA, Grobe JE, D'Amico D, Fonte C, Wilson A, Stiller RL. 1996. Low-dose nicotine nasal spray use and effects during initial smoking cessation. Experimental and Clinical Psychopharmacology 4:157-165.
103. Perkins KA, Sanders M, D'Amico D, Wilson A. 1997a. Nicotine discrimination and self-administration as a function of smoking status. Psychopharmacology 131:361-370.
104. Perkins KA, Grobe JE, Fonte C. 1997b. The influence of acute smoking exposure on the subsequent reinforcing value of smoking. Experimental and Clinical Psychopharmacology 5:277-285.
105. Perkins KA, Gerlach D, Vender J, Grobe JE. 1999a. Sex differences in the acute reinforcing effects of visual and olfactory cigarette smoke stimuli. Manuscript under review.
106. Perkins KA, Fonte C, Grobe JE. In press. Sex differences in the acute effects of cigarette smoking on the reinforcing value of alcohol. Behavioural Pharmacology.
107. Perkins KA, Levine M, Marcus M, Shiffman S, D'Amico D, Miller, A, Keins A, Ashcom J, Broge M. in press. Menstrual cycle phase and tobacco withdrawal after quitting smoking. Journal of Consulting and Clinical Psychology.
108. Peto R, Lopez AD, Boreham J, Thun M, Heath C, Doll R. 1996. Mortality from smoking worldwide, British Medical Bulletin 52:12-21.
109. Pierce JP, Fiore MC, Novotny TE, Hatziandreu EJ, Davis RM. 1989. Trends in cigarette smoking in the United States. Journal of the American Medical Association 261:61-65.
110. Pierce JP, Lee L, Gilpin EA. 1994. Smoking initiation by adolescent girls, 1944 through 1988: an association with targeted advertising. Journal of the American Medical Association 271:608-611.
111. Pomerleau CS, Pomerleau OF, Garcia AW. 1991. Biobehavioral research on nicotine use in women. British Journal of Addiction 86:527-531.
112. Pomerleau CS, Garcia AW, Pomerleau OF, Cameron OG. 1992. The effects of menstrual phase and nicotine abstinence on nicotine intake and on biochemical and subjective measures in women smokers: a preliminary report. Psychoneuroendocrinology 17:627-638.
113. Pomerleau CS, Tate JC, Lumley MA, Pomerleau OF. 1994a. Gender differences in prospectively versus retrospectively assessed smoking withdrawal symptoms. Journal of Substance Abuse 6:433-440.
114. Pomerleau CS, Cole PA, Lumley MA, Marks JL, Pomerleau OF. 1994b. Effects of menstrual cycle phase on nicotine, alcohol, and caffeine intake in smokers. Journal of Substance Abuse 6:227-234.
115. Prescott E, Hippe M, Schnohr P, Hein HO, Vestbo J. 1998. Smoking and risk of myocardial infarction in women and men: longitudinal population study. British Medical Journal 316:1043-1047.
116. Robbins SJ, Ehrman RN, Childress AR, O'Brien CP. 1999. Comparing levels of cocaine cue reactivity in male and female outpatients. Drug and Alcohol Dependence 53:223-230.
117. Roberts AJ, Smith AD, Weiss F, Rivier C, Koob GF. 1998. Estrous cycle effects on operant responding for ethanol in female rats. Alcohol: Clinical and Experimental Research 22:1564-1569.
118. Roberts DCS, Bennett SAL, Vickers GL. 1989. The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats. Psychopharmacology 98:408-411.
119. Roberts TA, Pennebaker JW. 1995. Gender differences in perceiving internal states: toward a his-and-hers model of perceptual cues. Advances in Experimental Social Psychology 27:143-175.
120. Robinson LA, Klesges RC, Zbikowski SM, Glaser R. 1997. Predictors of risk for different stages of adolescent smoking in a biracial sample. Journal of Consulting and Clinical Psychology 65:653-662.
121. Rolls BJ, Kim-Harris S, Fischman MW, Foltin RW, Moran TH, Stoner SA. 1994. Satiety after pre-loads with different amounts of fat and carbohydrate: implications for obesity. American Journal of Clinical Nutrition 60:476-487.
122. Rose JE, Corrigall WA. 1997. Nicotine self-adminstration in animals and humans: similarities and differences. Psychopharmacology 130:28-40
123. Rose JE, Behm FM, Levin ED. 1993. Role of nicotine dose and sensory cues in the regulation of smoke intake. Pharmacology, Biochemistry and Behavior 44:891-900.
124. Rose JE, Tashkin DP, Ertle A, Zinser MC, Lafer R. 1985. Sensory blockade of smoking satisfaction. Pharmacology, Biochemistry, and Behavior 23:289-293.
125. Rose JS, Chassin L, Presson CC, Sherman SJ. 1996. Demographic factors in adult smoking status: mediating and moderating influences. Psychology of Addictive Behaviors 10:28-37.
126. Rosecrans JA. 1971. Effects of nicotine on behavioral arousal and brain 5-hydroxytryptamine function in female rats selected for differences in activity. European Journal of Pharmacology 14:29-37.
127. Rosecrans JA, Schechter MD. 1972. Brain area nicotine levels in male and female rats of two strains. Archives of International Pharmacodynamics and Therapeutics 196:46-54
128. Royce JM, Corbett K, Sorensen G, Ockene J. 1997. Gender, social pressure, and smoking cessation: the Community Intervention Trial for Smoking Cesssation (COMMIT) at baseline. Social Science and Medicine 44:359-370.
129. Sayette MA, Parrott DJ. 1999. Effects of olfactory stimuli on urge reduction in smokers. Exper Clin Psychopharmacol 7:151-159.
130. Schechter MD, Rosecrans JA. 1971. CNS effect of nicotine as the discriminative stimulus for the rat in a t-maze. Life Sciences 10:821-832
131. Shiffman S. 1993. Smoking cessation treatment: any progress? Journal of Consulting and Clinical Psychology 61:718-722.
132. Sidney S, Tekawa I, Friedman G. 1989. Mentholated cigarette use among multiphasic examinees, 1979-86. American Journal of Public Health 79:1415-1416.
133. Smith L, Lang W. 1980. Changes occurring in self-administration of nicotine by rats over a 28-day period. Pharmacology, Biochemistry, and Behavior 9:387-389.
134. Sofuoglu M, Dudish-Poulsen S, Nelson D, Pentel PR, Hatsukami DK. 1999. Gender differences in the subjective effects from multiple deliveries of smoked cocaine in humans. Experimental and Clinical Psychopharmacology 7:274-283.
135. Steinberg JL, Cherek DR. 1989. Menstrual cycle and cigarette smoking behavior. Addictive Behaviors 14:173-179.
136. Stewart J, Woodside B, Shaham Y. 1996. Ovarian hormones do not affect the initiation and maintenance of intravenous self-administration of heroin in the female rat. Psychobiology 24:154-159.
137. Swan AV, Creeser R, Murray M. 1990. When and why children first start to smoke. International Journal of Epidemiology 19:323-330.
138. Swan GE, Ward MN, Carmelli D, Jack LM. 1993. Differential rates of relapse in subgroups of male and female smokers. Journal of Clinical Epidemiology 46:1041-1053.
139. Swan GE, Jack LM, Ward MM. 1997. Subgroups of smokers with different success rates after use of transdermal nicotine. Addiction 92:207-218.
140. Transdermal Nicotine Study Group. 1991. Transdermal nicotine for smoking cessation. Journal of the American Medical Association 266: 3133-3138.
141. Tyndale RF, Pianezza M, Sellers EM. 1998. Genetically deficient CYP2A6 provides protection against tobacco dependence and lowers cigarette consumption. Problems of Drug Dependence 1998, NIDA Research Monograph.
142. US Department of Health and Human Services. 1988. The Health Consequences of Smoking: Nicotine Addiction. A Report of the Surgeon General. Washington DC: US Government Printing Office.
143. US Department of Health and Human Services. 1989. Reducing the Health Consequences of Smoking: A Report of the Surgeon General. Washington DC: US Government Printing Office.
144. Valera S, Ballivet M, Bertrand D. 1992. Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proceedings of the National Academy of Sciences 89:9949-9953.
145. van Haaren F, Anderson K. 1994. Sex differences in schedule-induced alcohol consumption. Alcohol 11:35-40.
146. Webber J, MacDonald IA. 1993. A comparison of the cardiovascular and metabolic effects of incremental versus continuous dose adrenaline infusions in men and women. International Journal of Obesity 17:37-43.
147. Westman, EC, Behm FM, Rose JE. 1996. Airway sensory replacement as a treatment for smoking cessation. Drug Development Research 38:257-262.
148. Wetter D, Kenford SL, Smith SS, Fiore MC, Jorenby DE, Baker TB. 1999a. Gender differences in smoking cessation. Journal of Consulting and Clinical Psychology 67:555-562.
149. Wetter D, Fiore MC, Young TB, McClure J, deMoor CA, Baker TB. 1999b. Gender differences in response to nicotine replacement therapy: objective and subjective indices of tobacco withdrawal. Experimental and Clinical Psychopharmacology 7:135-144.
150. Whitlock EP, Vogt TM, Hollis JF, Lichtenstein E. 1997. Does gender affect response to a brief clinic-based smoking intervention? American Journal of Preventive Medicine 13:159-166.
151. Wilson D, Taylor A, Roberts L. 1995. Can we target smoking groups more effectively? A study of male and female heavy smokers. Preventive Medicine 24:363-368.
152. Wise R. 1987. Intravenous drug self-administration: a special case of positive reinforcement. In M Bozarth, ed. Methods of Assessing the Reinforcing Properties of Abused Drugs. New York, Springer-Verlag, pp. 117-141.
153. Yanagita T, Ando K, Wakasa Y, Shimada A. 1994. Behavioral and bochemical analysis of the dependence properties of nicotine. Proceedings of the International Symposium on Nicotine: 1-9.
154. Yilmaz O, Kanit L, Okur BE, Pogun S. 1997. Effects of nicotine on active avoidance learning in rats: sex differences. Behavioural Pharmacology 8:253-260.
155. Zang EA, Wynder EL. 1996. Differences in lung cancer risk between men and women: examination of the evidence. Journal of the National Cancer Institute 88:183-192.